SCHEMBL6156589

SCHEMBL6156589

CCOC(=O)CCc1cn(Cc2ccc(OCc3csc(-c4ccccc4)n3)cc2)nc1OCC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.49
RAB9A P51151 6/20 0.42
TP53 P04637 4/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
NPC1 O15118 4/20 0.42
NFKB1 P19838 2/20 0.42
NFKB2 Q00653 2/20 0.42
RELA Q04206 2/20 0.42
TSHR P16473 2/20 0.42
PKM P14618 1/20 0.42
HSD17B10 Q99714 1/20 0.42
MAPT P10636 4/20 0.41
KLKB1 P03952 1/20 0.40
KLK1 P06870 1/20 0.40
TMEM97 Q5BJF2 1/20 0.39
SIGMAR1 Q99720 1/20 0.39
KDM4E B2RXH2 2/20 0.39
POLB P06746 2/20 0.39
PPARA Q07869 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sipoglitazar SCHEMBL5380746 0.93 ALDH1A1 (0.47) ALDH1A1RAB9ATP53SMN1; SMN2NPC1
SCHEMBL5373797 0.91 ALDH1A1 (0.47) ALDH1A1RAB9ATP53SMN1; SMN2NPC1
SCHEMBL5382686 0.90 ALDH1A1 (0.41) ALDH1A1RAB9ATP53SMN1; SMN2NPC1
SCHEMBL5392101 0.86 CYSLTR2 (0.41) ALDH1A1KLKB1PPARACYSLTR2CYSLTR1
SCHEMBL5374629 0.85 PPARG (0.46) ALDH1A1PPARAL3MBTL1PPARGPPARD
SCHEMBL5381015 0.85 ALOX5AP (0.42) PPARACYSLTR2CYSLTR1PPARGPPARD
SCHEMBL5387654 0.85 FFAR1 (0.54) ALDH1A1TP53HSD17B10MAPTKDM4E
SCHEMBL5377258 0.84 ALDH1A1 (0.48) ALDH1A1RAB9ATP53SMN1; SMN2NPC1
SCHEMBL5387466 0.83 MAPT (0.44) RAB9ATP53SMN1; SMN2MAPTKDM4E
SCHEMBL5387742 0.83 L3MBTL1 (0.46) ALDH1A1PPARAL3MBTL1PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014813-A1 Process for production of pyrazole compounds TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-01-20 US disclosed
EP-1445254-A1 PROCESS FOR PRODUCTION OF PYRAZOLE COMPOUNDS Takeda Chemical Industries, Ltd. (JP) 2004-08-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014813-A1 Process for production of pyrazole compounds REN, CYP11B1, CYP11B2 ALDH1A1 1132/4885RAB9A 2309/4885TP53 717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.